loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Capsule Delayed Release Finished Formulations containing STARCH, PREGELATINIZED CORN? Find Corn Starch based pharmaceutical excipients on PharmaCompass.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Corn Starch

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5BUDESONIDE

    02 1DEXILANT

    03 1ESOMEPRAZOLE MAGNESIUM

    04 1ESOMEPRAZOLE STRONTIUM

    05 1FENOFIBRIC ACID

    06 1NEXIUM 24HR

    07 1ORTIKOS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    DR REDDYS LABS SA
    India
    arrow
    CPhI Worldwide, Milan
    Booth #24A41
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206623

    Country : US

    Patented : No

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS ELIZABETH

    CHOLINE FENOFIBRATE

    arrow
    FNCE 2024
    Not Confirmed
    ACTAVIS ELIZABETH
    Ireland
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 200920

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    AMNEAL PHARMS

    BUDESONIDE

    arrow
    FNCE 2024
    Not Confirmed
    AMNEAL PHARMS
    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206200

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ASTRAZENECA LP

    ESOMEPRAZOLE MAGNESIUM

    arrow
    FNCE 2024
    Not Confirmed
    ASTRAZENECA LP
    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ESOMEPRAZOLE MAGNESIUM

    Drug : NEXIUM 24HR

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 204655

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    AUROBINDO PHARMA

    ESOMEPRAZOLE MAGNESIUM

    arrow
    FNCE 2024
    Not Confirmed
    AUROBINDO PHARMA
    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ESOMEPRAZOLE MAGNESIUM

    Drug : ESOMEPRAZOLE MAGNESIUM

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 209339

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    BARR LABS DIV TEVA

    BUDESONIDE

    arrow
    FNCE 2024
    Not Confirmed
    BARR LABS DIV TEVA
    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 90379

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    BELCHER

    ESOMEPRAZOLE STRONTIUM

    arrow
    FNCE 2024
    Not Confirmed
    BELCHER
    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ESOMEPRAZOLE STRONTIUM

    Drug : ESOMEPRAZOLE STRONTIUM

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 202342

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NATCO

    BUDESONIDE

    arrow
    FNCE 2024
    Not Confirmed
    NATCO
    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206724

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TAKEDA PHARMS USA

    DEXLANSOPRAZOLE

    arrow
    FNCE 2024
    Not Confirmed
    TAKEDA PHARMS USA
    Japan
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DEXLANSOPRAZOLE

    Drug : DEXILANT

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 22287

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    RISING PHARMA

    BUDESONIDE

    arrow
    FNCE 2024
    Not Confirmed
    RISING PHARMA
    Country
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 207367

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF